牛唐01-06 11:36
$Albireo Pharma(ALBO)$ 更新了药物Bylvay在2021年的业绩预期，从300~400万美元，提升到700~800万美元。$Mirum制药(MIRM)$ $基石药业-B(02616)$
| 今开：19.41 | 昨收：19.36 |
| 最高：19.41 | 最低：19.05 |
| 涨停价： | 跌停价： |
| 总市值：374299219 |
牛唐01-06 11:36
$Albireo Pharma(ALBO)$ 更新了药物Bylvay在2021年的业绩预期，从300~400万美元，提升到700~800万美元。$Mirum制药(MIRM)$ $基石药业-B(02616)$
医药魔方2021-07-22 09:35
7月20日，美国FDA批准Albireo公司Bylvay (odevixibat)上市，用于3个月以上进行性家族性肝内胆汁淤积症(PFIC)所有亚型患者瘙痒的治疗。这是FDA批准的首款用于这类群体的疗法。每日1次，无需冷藏可作为胶囊或撒在食物上服用。值得注意的是，就在昨日该产品在欧盟获得全球首批。 PFIC是一种罕见的儿...
产业链观察2021-05-21 20:10
药闻| EMA正面建议在特殊情况下批准$Albireo Pharma(ALBO)$ 的Bylvay（odevixibat）的行销许可MAA，用于治疗进行性家族性肝内胆汁淤积症（PFIC）.
Albireo Pharma(ALBO)2021-04-28 04:12
$Albireo Pharma(ALBO)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-21-055593 Act: 34 Size: 2 MB 网页链接
Albireo Pharma(ALBO)2021-04-28 04:12
$Albireo Pharma(ALBO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-21-055598 Act: 34 Size: 846 KB 网页链接
Albireo Pharma(ALBO)06-18 04:12
$Albireo Pharma(ALBO)$ 8-K Current report, item 5.07 Accession Number: 0001104659-22-072382 Act: 34 Size: 203 KB 网页链接
Albireo Pharma(ALBO)05-17 05:18
$Albireo Pharma(ALBO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-22-061289 Act: 34 Size: 308 KB 网页链接
Albireo Pharma(ALBO)05-17 05:12
$Albireo Pharma(ALBO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-22-008984 Act: 34 Size: 4 MB 网页链接
美股滚雪球05-10 15:09
今年市场青睐有收入的小药企，尤其罕见病药物上市的药企，销售相对不是那么难，比如$Albireo Pharma(ALBO)$ 、$Mirum制药(MIRM)$ 、$Biocryst医药(BCRX)$
Albireo Pharma(ALBO)04-21 20:06
$Albireo Pharma(ALBO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-22-048088 Act: 34 Size: 346 KB 网页链接
Albireo Pharma(ALBO)06-18 04:12
$Albireo Pharma(ALBO)$ 8-K Current report, item 5.07 Accession Number: 0001104659-22-072382 Act: 34 Size: 203 KB 网页链接查看全文
Albireo Pharma(ALBO)05-17 05:18
$Albireo Pharma(ALBO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-22-061289 Act: 34 Size: 308 KB 网页链接查看全文
Albireo Pharma(ALBO)05-17 05:12
$Albireo Pharma(ALBO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-22-008984 Act: 34 Size: 4 MB 网页链接查看全文
美股滚雪球05-10 15:09
今年市场青睐有收入的小药企，尤其罕见病药物上市的药企，销售相对不是那么难，比如$Albireo Pharma(ALBO)$ 、$Mirum制药(MIRM)$ 、$Biocryst医药(BCRX)$查看全文
Albireo Pharma(ALBO)04-26 04:48
$Albireo Pharma(ALBO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-025523 Size: 5 KB 网页链接查看全文
Albireo Pharma(ALBO)04-26 04:48
$Albireo Pharma(ALBO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-025524 Size: 5 KB 网页链接查看全文
Albireo Pharma(ALBO)04-26 04:48
$Albireo Pharma(ALBO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-025525 Size: 5 KB 网页链接查看全文
Albireo Pharma(ALBO)04-26 04:48
$Albireo Pharma(ALBO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-025527 Size: 5 KB 网页链接查看全文
Albireo Pharma(ALBO)04-26 04:48
$Albireo Pharma(ALBO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-025526 Size: 5 KB 网页链接查看全文
Albireo Pharma(ALBO)04-26 04:48
$Albireo Pharma(ALBO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-025529 Size: 5 KB 网页链接查看全文
$Albireo Pharma(ALBO)$ 8-K Current report, item 5.07 Accession Number: 0001104659-22-072382 Act: 34 Size: 203 KB 网页链接
$Albireo Pharma(ALBO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-22-061289 Act: 34 Size: 308 KB 网页链接
$Albireo Pharma(ALBO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-22-008984 Act: 34 Size: 4 MB 网页链接
$Albireo Pharma(ALBO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-025523 Size: 5 KB 网页链接
$Albireo Pharma(ALBO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-025524 Size: 5 KB 网页链接
$Albireo Pharma(ALBO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-025525 Size: 5 KB 网页链接
$Albireo Pharma(ALBO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-025527 Size: 5 KB 网页链接
$Albireo Pharma(ALBO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-025526 Size: 5 KB 网页链接
$Albireo Pharma(ALBO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-025529 Size: 5 KB 网页链接
$Albireo Pharma(ALBO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-025522 Size: 10 KB 网页链接